🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,328 results for “Xiyuan Hospital of China Academy of Chinese Medical Sciences” Clear

  1. Edaravone Dexborneol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chemo Brain

    approved small molecule active

    1 trial

  2. Edoxaban

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-Valvular Atrial Fibrillation

    approved small molecule completed

    1 trial

  3. Eldecalcitol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Osteoporosis in Postmenopausal Women

    approved small molecule completed

    1 trial

  4. Empagliflozin 10 MG

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pre-Heart Failure

    approved small molecule active

    1 trial

  5. Enhanced dermatologic management

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    NSCLC (Advanced Non-small Cell Lung Cancer)

    approved other active

    1 trial

  6. Entecavir+Fuzheng Huayu+TCM Granule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B Virus Related Cirrhosis

    approved small molecule active

    1 trial

  7. Entecavir, Adefovir

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Hepatitis B

    approved small molecule active

    1 trial

  8. Epirubicin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Carcinoma, Hepatocellular

    approved small molecule active

    1 trial

  9. Etoposide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Mantle Cell Lymphoma

    approved small molecule completed

    1 trial

  10. Exenatide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Type 2 Diabetes Mellitus

    approved small molecule completed

    1 trial

  11. Ferric derisomaltose

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Heart Failure With Reduced Ejection Fraction

    approved small molecule active

    1 trial

  12. Ferric derisomaltose

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Heart Failure With Preserved Ejection Fraction

    approved small molecule active

    1 trial

  13. Fespixon Cream

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Diabetic Foot Ulcer (DFU)

    approved small molecule terminated

    1 trial

  14. Fluoxetine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Depressive Disorder

    approved small molecule active

    1 trial

  15. FuKe Qianjin Capsules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Endometritis

    approved small molecule active

    1 trial

  16. Glycopyrronium

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Postoperative Nausea and Vomiting

    approved small molecule active

    1 trial

  17. Group A (the standard 2HRZE/4HR regimen）

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pulmonary Tuberculosis TB in Sputum: (+) Microscopy

    approved small molecule completed

    1 trial

  18. Guilingji Capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Oligospermia

    approved small molecule active

    1 trial

  19. Guli capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Knee Osteoarthritis

    approved small molecule active

    1 trial

  20. Hemodialysis with Polymethylmethacrylate Artificial Kidney

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Uremia

    approved other completed

    1 trial

  21. ICS+LABA

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Bronchiectasis

    approved small molecule completed

    1 trial

  22. Imipenem

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sepsis

    approved small molecule active

    1 trial

  23. Inactivated COVID-19 vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19

    approved mab active

    1 trial

  24. Inactivated Polio Vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Vaccination

    approved mab completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources